ORIGINAL RESEARCH article
Front. Med.
Sec. Hematology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1609692
Global, regional, and national burden of Multiple myeloma, 1990 to 2021 and predictions to 2035: An analysis of the Global Burden of Disease Study 2021
Provisionally accepted- 1Southwest Medical University, Luzhou, China
- 2Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background and objective: Multiple myeloma (MM) is the second most common haematologic malignancy. This study aimed to assess the global burden of multiple myeloma across 204 countries and territories from 1990 to 2021.The data for this study were obtained from the Global Burden of Disease (GBD) 2021 dataset, which provides comprehensive information on the global and regional burden of 369 diseases, injuries, and 88 risk factors across 204 countries and territories from 1990 to 2021. We analyzed the incidence, mortality, disability-adjusted life years (DALYs) and disease-related risk factors of MM from 1990 to 2021.Age-standardized incidence rate (ASIR), age-standardized mortality rate (ASMR) and age-standardized DALYs rate (ASDR) were calculated and analyzed. We also analyzed trends over time by gender and age, and assessed the impact of Socio-demographic Index (SDI) on disease burden. In addition, the global burden of MM from 2021 to 2035 was predicted by a Bayesian Age-Period-Cohort (BAPC) model.In 2021, there were 148755 cases of MM globally. From 1990 to 2021, the global ASIR, ASMR and ASDR increased(EAPC = 0.48, 0.09 and 0.06, respectively). In general, the ASIR, ASMR and ASDR of MM and SDI levels are positive correlated, as regions with higher SDI levels normally have higher ASIR, ASMR and ASDR. The incidence and mortality rates were higher in males than in females in all age groups, and increased with age before 90 years. We projected that the ASIR, ASMR and ASDR of MM would obviously increase over the next dozen years through BAPC model.The findings in this study offer valuable insights into the global distribution and magnitude of the MM burden, which may be instructive for better making public health policy and reasonably allocating medical source.
Keywords: Multiple Myeloma, global burden of disease 2021, Incidence, Mortality, Disability-adjusted life years
Received: 10 Apr 2025; Accepted: 14 Jul 2025.
Copyright: © 2025 Miao, Zhao, Hanyu, Zeng, Wang, Luo, Yang and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jiafu Yang, Southwest Medical University, Luzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.